Innate Pharma SA banner

Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.25 EUR -1.73% Market Closed
Market Cap: €117.2m

During the last 3 months Innate Pharma SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 23% over this period (open performance analysis).

The last transaction was made on Jun 8, 2022 by Herve Brailly , who sold 29.2k EUR worth of IPH shares.

Last Transactions:
Herve Brailly
€-29.2k
Dfc Langlois Société Civile Personne Morale Liée À Patrick L
€+21.6k
Dfc Langlois Société Civile Personne Morale Liée À Patrick L
€+21.4k
Laure-Hélène Mercier
€+280k
Laure-Hélène Mercier
€+280k
Pierre Dodion
€+22.4k
Laure-Hélène Mercier
€+22.4k
Herve Brailly
€-311.2k
Eric Vivier
€-133.7k
Eric Vivier
€+120.6k
Novo Nordisk A/S
€+37.2m
Herve Brailly
€-357k
Jerome Tiollier
€-347.7k
Novo Nordisk A/S
€+600.8k
Novo Nordisk A/S
€+717k
Dfc Langlois Societe Civile Personne Morale Liée À Patrick Lan
€+57k
Novo Nordisk A/S
€+708.9k
Rozencweig Marcel
€-545.4k
View All Transactions

During the last 3 months Innate Pharma SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 23% over this period (open performance analysis).

The last transaction was made on Jun 8, 2022 by Herve Brailly , who sold 29.2k EUR worth of IPH shares.

Sold
0-3
months
0 EUR
0
3-6
months
0 EUR
0
6-9
months
0 EUR
0
9-12
months
0 EUR
0
Bought
0-3
months
No Insider Transactions
0
0 EUR
3-6
months
No Insider Transactions
0
0 EUR
6-9
months
No Insider Transactions
0
0 EUR
9-12
months
No Insider Transactions
0
0 EUR

Innate Pharma SA
Insider Trading Chart

Innate Pharma SA
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Innate Pharma SA
Last Insider Transactions

Global
Insiders Monitor

Innate Pharma SA
Glance View

Market Cap
117.2m EUR
Industry
Biotechnology

Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. The company is headquartered in Marseille, Paca and currently employs 215 full-time employees. The company went IPO on 2006-10-31. The firm identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The firm develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The firm works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The firm operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

IPH Intrinsic Value
HIDDEN
Show

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett